Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Customers Bancorp
CUBI
$2.66B
| $7.53M | 0.01% |
413,480
-2,849
| -0.7% | -$57K |
|
1652
Corcept Therapeutics
CORT
$12.4B
| $7.51M | 0.01% |
562,269
+56
| +0% | +$740 |
|
1653
Amdocs
DOX
$5.92B
| $7.46M | 0.01% |
127,389
+1,979
| +2% | +$124K |
|
|
TGI
1654
DELISTED
Triumph Group
TGI
| $7.45M | 0.01% |
648,091
+15,623
| +2% | +$271K |
|
|
APTI
1655
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $7.43M | 0.01% |
195,850
+3,686
| +2% | +$125K |
|
|
AERI
1656
DELISTED
Aerie Pharmaceuticals
AERI
| $7.43M | 0.01% |
205,886
-1,327
| -0.6% | -$62.3K |
|
1657
Methode Electronics
MEI
$496M
| $7.42M | 0.01% |
318,338
+18,075
| +6% | +$510K |
|
1658
OFG Bancorp
OFG
$2.23B
| $7.41M | 0.01% |
450,330
+77,900
| +21% | +$1.31M |
|
|
DPLO
1659
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $7.39M | 0.01% |
549,223
+22,246
| +4% | +$375K |
|
1660
Cavco Industries
CVCO
$4.22B
| $7.37M | 0.01% |
56,545
+3,805
| +7% | +$688K |
|
|
NXGN
1661
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $7.37M | 0.01% |
486,196
-43,867
| -8% | -$753K |
|
1662
Matrix Service
MTRX
$326M
| $7.34M | 0.01% |
408,949
+1,626
| +0.4% | +$33.3K |
|
1663
S&T Bancorp
STBA
$1.84B
| $7.34M | 0.01% |
193,887
+794
| +0.4% | +$32K |
|
1664
Coca-Cola Consolidated
COKE
$12.5B
| $7.32M | 0.01% |
412,790
-127,830
| -24% | -$2.37M |
|
1665
Dillards
DDS
$9.19B
| $7.32M | 0.01% |
121,331
-9,874
| -8% | -$679K |
|
1666
Artisan Partners
APAM
$2.79B
| $7.31M | 0.01% |
330,521
+19,733
| +6% | +$526K |
|
|
CPLG
1667
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $7.3M | 0.01% |
595,811
+288,183
| +94% | +$4.36M |
|
1668
Cactus
WHD
$5.21B
| $7.29M | 0.01% |
265,870
-86,379
| -25% | -$2.83M |
|
|
BRSP
1669
BrightSpire Capital
BRSP
$634M
| $7.28M | 0.01% |
461,126
+4,879
| +1% | +$92.8K |
|
|
CRAY
1670
DELISTED
Cray, Inc.
CRAY
| $7.28M | 0.01% |
337,139
-4,053
| -1% | -$91.6K |
|
1671
Cimpress
CMPR
$2.39B
| $7.28M | 0.01% |
70,355
-277
| -0.4% | -$32.2K |
|
1672
SM Energy
SM
$7.8B
| $7.25M | 0.01% |
468,633
-9,838
| -2% | -$228K |
|
1673
Interface
TILE
$1.99B
| $7.24M | 0.01% |
508,081
-106,090
| -17% | -$1.82M |
|
|
MB
1674
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $7.23M | 0.01% |
198,642
+3,141
| +2% | +$95.6K |
|
1675
Varex Imaging
VREX
$472M
| $7.2M | 0.01% |
303,914
+34,491
| +13% | +$876K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.